银屑病关节炎发作评估:FLARE问卷与PsAID-12的比较验证
本研究为横断面研究,纳入150例银屑病关节炎患者,验证FLARE问卷并比较其与PsAID-12评估疾病发作的能力。FLARE问卷显示良好的内部一致性和重测信度,但与独立问题的一致性中等;ROC分析显示FLARE问卷与PsAID-12性能相似,PsAID-12可能足以用于定义发作。
要点
- FLARE问卷内部一致性良好(α=0.88),重测信度良好(ICC=0.76)。
- FLARE问卷定义的发作与患者自报发作一致性中等(κ=0.59)。
- PsAID-12与FLARE问卷在识别发作上性能相似,PsAID-12或可替代。
核心结论
- PsAID-12可用于定义银屑病关节炎的发作。
研究设计与样本
- 横断面研究,纳入150例年龄≥18岁的银屑病关节炎患者,采用标准方案收集数据。
主要发现
- FLARE问卷内部一致性良好(Cronbach's α=0.88,95%CI 0.85至0.90)。
- FLARE问卷重测信度良好(ICC=0.76,p<0.001,95%CI 0.59至0.87)。
- FLARE问卷定义的发作与独立问题的一致性中等(κ=0.59,95%CI 0.45至0.72)。
- ROC分析显示FLARE问卷AUC=0.90(95%CI 0.85至0.95),PsAID-12 AUC=0.83(95%CI 0.76至0.90),两者性能相似。
- PsAID-12切点≥3.13时,灵敏度0.72与特异度0.79达到最佳平衡。
关键数值与推荐
- PsAID-12切点≥3.13用于定义发作,灵敏度0.72,特异度0.79。
临床怎么用
- 在临床或研究中可使用PsAID-12(切点≥3.13)来定义银屑病关节炎的发作。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The psoriatic arthritis (PsA) FLARE Questionnaire was developed to study flares in PsA. We aimed to validate the FLARE Questionnaire and compare it with the Psoriatic Arthritis Impact of Disease 12-item Questionnaire (PsAID-12) to determine whether PsAID-12 was sufficient for assessing disease flares. METHODS: This cross-sectional study enrolled 150 patients aged ≥18 years. Data collection using a standard protocol consisted of demographic characteristics, patient-reported outcomes (including PsAID-12), cutaneous/musculoskeletal examination findings, routine labs, FLARE Questionnaire and a stand-alone question asking participants whether they believed they were experiencing a flare. Internal consistency of the FLARE Questionnaire was measured using Cronbach's α. Test-retest reliability was evaluated using the intraclass correlation coefficient (ICC) by administering the questionnaire twice to 51 patients, 1 week apart. Agreement between flare definition using the FLARE Questionnaire and the stand-alone question was determined using Cohen's κ. Associations between clinical features and flares self-reported by the stand-alone question were assessed using logistic regressions. The FLARE Questionnaire and PsAID-12 were compared against the stand-alone question using receiver operating characteristics (ROC) curve analysis. RESULTS: The FLARE Questionnaire displayed good internal consistency (α = 0.88, 95% CI 0.85 to 0.90), good test-retest reliability (ICC = 0.76, p<0.001, 95% CI 0.59 to 0.87), and moderate agreement between flare definition using the cut-off and stand-alone question (κ = 0.59, 95% CI 0.45 to 0.72). However, ROC analysis demonstrated that the FLARE Questionnaire (area under the curve (AUC) = 0.90, 95% CI 0.85 to 0.95) and PsAID-12 (AUC = 0.83, 95% CI 0.76 to 0.90) performed similarly. A PsAID-12 cut-off of ≥3.13 achieved the best balance between sensitivity (0.72) and specificity (0.79). CONCLUSIONS: PsAID-12 may be used for defining PsA flares.
引用
- Chronis NJ, Pereira D, Gao S, et al. Assessing flares in patients with psoriatic arthritis using questionnaires. RMD Open. 2026. PMID: 42259575. doi:10.1136/rmdopen-2026-006810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。